We aimed at addressing the role of late gadolinium enhancement (LGE) in arrhythmic risk stratification of LMNA-associated cardiomyopathy (CMP).

Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study / Peretto, G., Barison, A., Forleo, C., Di Resta, C., Esposito, A., Aquaro, G.D., Scardapane, A., Palmisano, A., Emdin, M., Resta, N., Santoni, A., Guaricci, A.I., Santobuono, V.E., Pepe, M., Favale, S., Ferrari, M., Benedetti, S., Della Bella, P., Sala, S.. - In: EUROPACE. - ISSN 1099-5129. - (2020). [Epub ahead of print] [10.1093/europace/euaa171]

Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study

Di Resta, Chiara;Esposito, Antonio;Palmisano, Anna;Ferrari, Maurizio;
2020-01-01

Abstract

We aimed at addressing the role of late gadolinium enhancement (LGE) in arrhythmic risk stratification of LMNA-associated cardiomyopathy (CMP).
2020
Cardiac magnetic resonance
Cardiomyopathy
LMNA mutation
Late gadolinium enhancement
Risk stratification
Sudden cardiac death
Ventricular arrhythmias
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/103738
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 38
social impact